Tumor Marker Panel, Female
Common tumor markers ordered for women; not diagnostic alone.
6 tests explainedAlso printed as Female Cancer Marker Panel, Tumor Markers (Women), Cancer Screen Panel, Female
Check your whole panel
Type the results from your report. Each one is placed on its usual range, with its status in words.
Type the results from your Tumor Marker Panel, Female report. Each one is placed on its usual range as you type.
Nothing you type here leaves your browser. Ranges differ a little between labs, so the range on your own report is the one your result is judged against.
The 6 tests in this panel
What each one measures and the range labs usually print for adults. Ranges differ a little between labs, so the range on your own report is the one your result is judged against.
CA-125 (Cancer Antigen 125)
A protein made by tissue lining the pelvis and belly. Doctors mainly use it to follow ovarian cancer, and many harmless conditions raise it too.
- Women
- 0–35 U/mL
CA 15-3 (Cancer Antigen 15-3)
A protein on breast and other gland cells. Doctors use it to follow breast cancer treatment, and many harmless conditions can raise it too.
- Adults
- 0–30 U/mL
CA 27.29
A protein from the same family as CA 15-3. Doctors use it to follow breast cancer treatment and recurrence, and harmless conditions can raise it too.
- Adults
- 0–38.6 U/mL
CEA (Carcinoembryonic Antigen)
A protein that some cancers release, mainly colorectal. It is used to follow people with cancer, not to screen healthy people.
- Adults
- 0–3.8 ng/mL
AFP (Alpha-Fetoprotein)
A protein made by a baby's liver before birth. Adults who aren't pregnant normally have very little. Doctors follow it in some liver and germ cell conditions.
- 18+
- 0–8.4 ng/mL
- Men, 18–30
- 0–5.7 ng/mL
- Women, 18–30
- 0–4.7 ng/mL
- Men, 31–50
- 0–6.9 ng/mL
CA 19-9 (Cancer Antigen 19-9)
A sugar-and-protein molecule that some digestive-system cancers release. Many harmless bile duct, liver and pancreas conditions raise it too.
- Adults
- 0–35 U/mL
Labs can include one more test in this panel that we haven’t written up yet.